Clinical trial
Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization…
NCT00395551 · Ophthalmic Consultants of Boston, Other · Completed
Key facts
| NCT number | NCT00395551 |
|---|---|
| Title | Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. |
| Official title | A Single Center Study of the Safety and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects With CNV Secondary to Causes Other Than AMD. |
| Lead sponsor | Ophthalmic Consultants of Boston, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization |
| Intervention type | Drug |
| Interventions | ranibizumab |
| Enrollment | 30 |
| Start date | Dec 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Nov 3, 2006 |
| Last update posted | Jan 8, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: